Back to news

Humacyte Presents Long-Term Clinical Data Demonstrating Low Atherosclerosis Susceptibility in Acellular Tissue Engineered Vessel

Globe Newswire•16/11/2026•08:00 ET
1

Key Highlights

  • ➤ATEV analysis covered 52 patients across five clinical trials
  • ➤Minimal lipid deposition averaged 0.6% of tissue area
  • ➤Over 95% of explants showed no or minor early atherosclerosis markers
  • ➤Only 4.7% showed atypical fatty streaks; none had vulnerable plaques
  • ➤Implant durations extended beyond five years in some patients

Expert Statements

Juan Wang, Principal Scientist at Humacyte

“Atherosclerosis is one of the long-term threats to any vascular graft. Until now there has been no long-term clinical evidence on how bioengineered vessels hold up against it.”

Juan Wang, Principal Scientist at Humacyte

“Across more than 50 patients, many with significant cardiovascular risk factors, we saw very little evidence of the disease taking hold in the ATEV, even years after implantation. We believe that these results support the long-term durability of the ATEV as a potential option for vascular surgeons to use in the operating room.”

Laura Niklason, Founder, President and Chief Executive Officer of Humacyte

“Durability is one of the most important questions surgeons ask about any vascular conduit.”

Laura Niklason, Founder, President and Chief Executive Officer of Humacyte

“This data, drawn from patients implanted for as long as five years, suggest that the ATEV’s biology works over time. That matters as we work to bring the ATEV to more patients including, if approved by the FDA, those who need long-term reliable access for hemodialysis.”

– Analysis of ATEVs from 52 patients across five clinical trials, some implanted for more than five years, found minimal lipid buildup and no evidence of vulnerable plaques.

– First long-term clinical evaluation of atherosclerosis susceptibility in a tissue engineered vessel.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in